Cite
Dose-finding study of oxaliplatin associated to capecitabinebased preoperative chemoradiotherapy in locally advanced rectal cancer
MLA
Rosa Manetta, et al. Dose-Finding Study of Oxaliplatin Associated to Capecitabinebased Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c8ab418cf545eaeb8c06d679e7876941&authtype=sso&custid=ns315887.
APA
Rosa Manetta, Gemma Bruera, Stefano Guadagni, Antonio Galvano, Antonio Russo, Mario Di Staso, P. Bonfili, Enrico Ricevuto, Corrado Ficorella, Ernesto Di Cesare, Roberto Vicentini, & Gino Coletti. (2018). Dose-finding study of oxaliplatin associated to capecitabinebased preoperative chemoradiotherapy in locally advanced rectal cancer.
Chicago
Rosa Manetta, Gemma Bruera, Stefano Guadagni, Antonio Galvano, Antonio Russo, Mario Di Staso, P. Bonfili, et al. 2018. “Dose-Finding Study of Oxaliplatin Associated to Capecitabinebased Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c8ab418cf545eaeb8c06d679e7876941&authtype=sso&custid=ns315887.